Audentes Therapeutics, Inc. (BOLD) Social Stream BOLD Home News Ratings Charts Warning: This security is no longer trading. Astellas completes acquisition of Audentes Therapeutics Audentes Therapeutics, Inc. (BOLD): $11.60 0.57 (+5.17%) POWR Rating Get Rating Component Grades Growth Get Rating Value Get Rating Momentum NR Stability NR Sentiment Get Rating Quality NR Add BOLD to Watchlist Sign Up Industry: Biotech Industry NR Ranked in industry See All 'A' Rated Buy Stocks Loading social stream, please wait... Most Popular Stories View All • When is the Next Bull Run for Stocks? • 3 Gold Stocks to Buy Poised for Success • 3 Internet Stocks Poised up for Rapid Growth in April • TXN vs. INTC Earnings Alert - Which Chip Stock Will Surge Ahead? • Updated 2024 Stock Market Outlook View All Top stories Get Free Updates Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Subscribe
Loading social stream, please wait...